DMI COVID-19 Resource Guide
The spread of COVID-19 has negatively impacted statewide infrastructure and reduced the availability of a wide number of Health and Prevention Sharing Network (HPSN) resources, which are essential for DMI partners and the individuals they serve.
In response to the COVID-19 (coronavirus) pandemic, NJ’s Drug Monitoring Initiative (DMI) has created a “New Jersey Resource Guide” to provide DMI partners and the public with links to relevant resources for a variety of topics.